5-14608775-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019018.3(OTULINL):āc.655T>Cā(p.Tyr219His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,610,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_019018.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTULINL | NM_019018.3 | c.655T>C | p.Tyr219His | missense_variant | 7/8 | ENST00000274217.4 | NP_061891.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTULINL | ENST00000274217.4 | c.655T>C | p.Tyr219His | missense_variant | 7/8 | 1 | NM_019018.3 | ENSP00000274217 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250220Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135384
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1458150Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 724674
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.655T>C (p.Y219H) alteration is located in exon 7 (coding exon 7) of the FAM105A gene. This alteration results from a T to C substitution at nucleotide position 655, causing the tyrosine (Y) at amino acid position 219 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at